Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia
Jaroslav Jelinek, Vazganush Gharibyan, Marcos R.H. Estecio, Kimie Kondo, Rong He, Woonbok Chung, Yue Lu, Nianxiang Zhang, Shoudan Liang, Hagop M. Kantarjian, Jorge E. Cortes, Jean Pierre J. Issa
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia'. Together they form a unique fingerprint.